Restrictions on NHS prescribing in Australia.
作者信息
Smith T
出版信息
Br Med J. 1979 Jan 13;1(6156):99-100. doi: 10.1136/bmj.1.6156.99.
Abstract
摘要
相似文献
1
Restrictions on NHS prescribing in Australia.
Br Med J. 1979 Jan 13;1(6156):99-100. doi: 10.1136/bmj.1.6156.99.
2
Restrictions on NHS prescribing in Australia.
Br Med J. 1979 Apr 14;1(6169):1018. doi: 10.1136/bmj.1.6169.1018-a.
3
"Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency.
Aust Health Rev. 2004 Nov 8;28(2):171-81. doi: 10.1071/ah040171.
4
Bringing in the big guns. U.S. attorney joins civil suits against Medco Health.
Mod Healthc. 2003 Jul 7;33(27):17.
5
The pharmaceutical situation in the Philippines.
Aust Health Rev. 2001;24(2):25-31. doi: 10.1071/ah010025.
6
Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.
Curr Oncol. 2019 Aug;26(4):266-269. doi: 10.3747/co.26.4867. Epub 2019 Aug 1.
7
[Family physicians resist high prescription risk].
MMW Fortschr Med. 2003 May 15;145(20):58.
8
Paying for prescriptions: programs that can help.
Pa Med. 2001 Winter;104(1):7.
9
Pharmaceutical Benefits Scheme restrictions on anti-epileptic drug prescribing promote unsafe and outdated practice.
Med J Aust. 2019 Jul;211(2):55-57.e1. doi: 10.5694/mja2.50246. Epub 2019 Jun 30.
10
PEI government announces catastrophic drug plan.
CMAJ. 2013 Jul 9;185(10):E432. doi: 10.1503/cmaj.109-4513. Epub 2013 Jun 10.
引用本文的文献
1
Limited lists of drugs: lessons from abroad.
Br Med J (Clin Res Ed). 1985 Feb 16;290(6467):532-4. doi: 10.1136/bmj.290.6467.532.
Zotero 插件